P128 Pooled safety analysis of adjudicated serious adverse events with the combination of tiotropium + olodaterol

R Buhl; K Tetzlaff; L Korducki; C Vogelmeier; L McGarvey

doi:10.1136/thoraxjnl-2015-207770.265

Article info

PDF

Poster sessions

Phenotypes and response to treatment in COPD

P128 Pooled safety analysis of adjudicated serious adverse events with the combination of tiotropium + olodaterol

Free

Authors

R Buhl 1Pulmonary Department, Mainz University Hospital, Mainz, Germany PubMed articles Google scholar articles
K Tetzlaff 2Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany PubMed articles Google scholar articles
L Korducki 3Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA PubMed articles Google scholar articles
C Vogelmeier 4Department for Respiratory Diseases, University of Marburg, Marburg, Germany PubMed articles Google scholar articles
L McGarvey 5Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK PubMed articles Google scholar articles

Citation

Buhl R, Tetzlaff K, Korducki L, et al

P128 Pooled safety analysis of adjudicated serious adverse events with the combination of tiotropium + olodaterol

Thorax 2015;70:A140-A141.

Publication history

First published November 12, 2015.

Online issue publication

September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password